Evidence map›Paper›PMID 41225618›Full record

ArticleBiomarker research2025

Global mapping of RNA N

Torunn Rønningen, Yong Zeng, Mai Britt Dahl, Junbai Wang, Tina Visnovska, Tone Møller Tannæs, Lars la Cour Poulsen, Akin Cayir, Stina Ingrid Alice Svensson, Marius Svanevik and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomarker research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Torunn RønningenEpiGen, Medical Division, Akershus University Hospital, Postboks 1000, Lørenskog, 1478, Norway.
Yong ZengPrincess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Mai Britt DahlDepartment of Clinical Molecular Biology, EpiGen, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Junbai WangDepartment of Clinical Molecular Biology, EpiGen, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Tina VisnovskaEpiGen, Medical Division, Akershus University Hospital, Postboks 1000, Lørenskog, 1478, Norway.
Tone Møller TannæsEpiGen, Medical Division, Akershus University Hospital, Postboks 1000, Lørenskog, 1478, Norway.
Lars la Cour PoulsenEpiGen, Medical Division, Akershus University Hospital, Postboks 1000, Lørenskog, 1478, Norway.
Akin CayirEpiGen, Medical Division, Akershus University Hospital, Postboks 1000, Lørenskog, 1478, Norway.
Stina Ingrid Alice SvenssonDepartment of Clinical Molecular Biology, EpiGen, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Marius SvanevikDepartment of Endocrinology, Obesity and Nutrition, Vestfold Hospital Trust, Tønsberg, Norway.
Jens Kristoffer HertelDepartment of Endocrinology, Obesity and Nutrition, Vestfold Hospital Trust, Tønsberg, Norway.
Jøran HjelmesæthDepartment of Endocrinology, Obesity and Nutrition, Vestfold Hospital Trust, Tønsberg, Norway.
Jon A KristinssonDepartment of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Tom MalaDepartment of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Matthias BlüherHelmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital, Leipzig, Germany.
Housheng Hansen HePrincess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Tone Gretland ValderhaugDepartment of Endocrinology, Obesity and Nutrition, Vestfold Hospital Trust, Tønsberg, Norway.
Yvonne BöttcherEpiGen, Medical Division, Akershus University Hospital, Postboks 1000, Lørenskog, 1478, Norway. yvonne.bottcher@medisin.uio.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObesity is a major health challenge and fat accumulation in visceral depots is more strongly associated with metabolic comorbidities than deposition in subcutaneous depots. Epitranscriptomic regulation of gene expression by N

methodsIn this study, we performed epitranscriptomic mapping of m

resultsWe here provide the first global map of m

conclusionsWe identify a catalogue of novel targets showing adipose tissue depot specific m

Indexed as

Adipose tissueEpitranscriptomicsFat distributionN6-methyladenosineObesity

Identifiers

PMID41225618
PMCPMC12613671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.